TÜBINGEN, DE AND BOSTON, MA / ACCESS Newswire / November 25, 2025 / CureVac N.V. (Nasdaq:CVAC)(CureVac or the Company), a ...
CureVac’s shareholders approved all proposals relating to BioNTech SE’s public exchange offer for all outstanding shares in CureVac (Offer) at the EGM with an approval rate of over 99.16% of the votes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback